In Brief: ICN Pharmaceuticals
This article was originally published in The Gray Sheet
Executive Summary
ICN Pharmaceuticals: Acquires Becton Dickinson's radioimmunoassay division, for an undisclosed amount, ICN announces May 8. The acquisition doubles ICN's radioimmunoassay activities, creating a $20 mil. unit. The B-D division, which markets anemia and thyroid diagnostics, had 1994 sales of $12 mil...